Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Eiger BioPharmaceuticals, Inc.
3199
Eiger BioPharmaceuticals, Inc.
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Eiger is a biopharmaceutical company developing new antiviral agents againstnovel targets in the treatment of hepatitis.
Suggest edits
Founded
2008
Raised
$28M
Follow us
Companies in the same industry
Kallyope
Biond Solutions (BI/OND)
Brii Biosciences
Antios Therapeutics
Haihe Biopharma
Ark Biosciences
IASO Biotherapeutics
Vaxess Technologies
Oncothyreon
Tricida, Inc.
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$25,000,000
Post-IPO debt - 2017
Oxford Finance
$3,000,000
Venture capital - 2016
Team Size
2
Employees
I work here
Location
United States
Headquarters
Explore United States
$25,000,000
Post-IPO debt
biospace
Eiger Biopharma Completes 25 Million Debt Financing With Oxford Finance
